About One in Six New Jerseyans Say They Won’t Get COVID-19 Vaccine

Rutgers-Eagleton poll finds two-thirds of parents will definitely or probably vaccinate their children or have done so

Newswise — NEW BRUNSWICK, N.J. (June 3, 2021) – Seventy-three percent of New Jerseyans say they have received at least one dose of a COVID-19 vaccine, and while another 10 percent say they will likely roll up their sleeve for it, 16 percent remain unwilling, according to the latest Rutgers-Eagleton Poll. 

The large number of Garden State residents getting vaccinated is a drastic change from the widespread vaccine hesitancy last fall before Pfizer and Moderna’s initial news of successful vaccine trials. 

Older residents, higher income residents, and residents with higher levels of education are all more likely than their counterparts to say they have received at least one dose of a vaccine, as are exurban (81 percent), suburban (77 percent), and urban (75 percent) residents compared to those living in other regions of the state. Republicans (32 percent) and independents (34 percent) are twice as likely as Democrats (16 percent) to report not getting a dose yet. 

Among people unwilling to get vaccinated, 67 percent cite a concern about side effects (down from 80 percent), 58 percent cite a distrust in the government and 57 percent cite the belief that the vaccines were developed and tested too quickly as “major reasons” for their resistance. 

Fifty-five percent of those vaccine-hesitant say a “major reason” is that they feel they do not need it (up from 25 percent). Forty-nine percent cite wanting to know more about how the vaccine works (down from 82 percent), and 47 percent cite seeing too many mistakes from the medical system in the past as “major reasons.” Thirty-three percent say a “major reason” is that they simply do not get vaccines in general. 

When asked what would make them more likely to get the vaccine, 49 percent of those currently unwillingly say nothing would change their mind; 8 percent mention the need for more information, and 7 percent say they simply need more time. 

“The enduring nature of vaccine hesitancy for a small yet notable portion of the population in New Jersey resembles what we are seeing throughout the rest of the country,” said Ashley Koning, an assistant research professor and director of the Eagleton Center for Public Interest Polling (ECPIP) at Rutgers University–New Brunswick. “And while some of those unwilling may ultimately be convinced, others may not. Unfortunately, we know from current data that infection, hospitalization, and death rates are currently much higher for those who are unvaccinated compared to those who are immunized.” 

Among those vaccinated, 50 percent experienced no side effects; the rest mostly experienced mild (31 percent) or moderate (15 percent) side effects, while just 5 percent had severe ones. 

Among parents in the Garden State, 36 percent say they will definitely get their child vaccinated when a vaccine is available for their child’s age group; another 22 percent say they will probably get their child vaccinated; and 7 percent have already gotten their child vaccinated. Just over half (53 percent) say they will get their child vaccinated right away, while 43 percent say they will wait to see how the vaccines work; 4 percent are unsure. 

Seventy-two percent of New Jerseyans say they and/or someone they know has tested positive or been officially diagnosed with coronavirus. Among those who do not know someone who tested positive, 20 percent say they and/or someone they know most likely had coronavirus despite no official diagnosis or test. 

Concern over the coronavirus is at an all-time low. Forty-one percent are worried (14 percent “very,” 27 percent “somewhat”) that they or someone in their household will get sick from the coronavirus; this is down considerably from the fall (30 percent “very,” 41 percent “somewhat”). 

Results are from a statewide poll of 1,004 adults contacted by live interviewers on landlines and cell phones from May 21–29. The full sample has a margin of error of +/- 3.8 percentage points. 

# # #

ABOUT RUTGERS—NEW BRUNSWICK

Rutgers University–New Brunswick is where Rutgers, the State University of New Jersey, began more than 250 years ago. Ranked among the world’s top 60 universities, Rutgers’s flagship university is a leading public research institution and a member of the prestigious Association of American Universities. It is home to internationally acclaimed faculty and has 12 degree-granting schools and a Division I Athletics program. It is the Big Ten Conference’s most diverse university. Through its community of teachers, scholars, artists, scientists, and healers, Rutgers is equipped as never before to transform lives. 

ABOUT THE EAGLETON CENTER FOR PUBLIC INTEREST POLLING (ECPIP)

Home of the Rutgers-Eagleton Poll, ECPIP was established in 1971 and is the oldest and one of the most respected university-based state survey research centers in the United States. Now in its 48th year and with the publication of over 200 polls, ECPIP’s mission is to provide scientifically sound, non-partisan information about public opinion. To read more about ECPIP and view all of our press releases, published research, and data archive, please visit our website: eagletonpoll.rutgers.edu. You can also visit our Facebook and Twitter. 

ABOUT THE EAGLETON INSTITUTE OF POLITICS

The Eagleton Center for Public Interest Polling is a unit of the Eagleton Institute of Politics at Rutgers University-New Brunswick. The Eagleton Institute studies how American politics and government work and change, analyzes how the democracy might improve, and promotes political participation and civic engagement. The Institute explores state and national politics through research, education, and public service, linking the study of politics with its day-to-day practice. To learn more about Eagleton programs and expertise, visit eagleton.rutgers.edu



Filters close

Showing results

110 of 6123
Released: 4-Aug-2021 5:05 PM EDT
Canadian-Led International Study: Full-Dose Blood Thinners Benefit Moderately Ill COVID-19 Patients
University of Manitoba

The investigators discovered that in moderately ill patients full-dose heparin reduced the need for organ support compared to those who received lower-dose heparin.

Released: 4-Aug-2021 4:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Public
Released: 4-Aug-2021 2:05 PM EDT
A Study Reveals What Triggers Lung Damage During COVID-19
The Korea Advanced Institute of Science and Technology (KAIST)

A KAIST immunology research team found that a specific subtype of macrophages that originated from blood monocytes plays a key role in the hyper-inflammatory response in SARS-CoV-2 infected lungs, by performing single-cell RNA sequencing of bronchoalveolar lavage fluid cells.

Released: 4-Aug-2021 1:00 PM EDT
American Society of Anesthesiologists and Anesthesia Patient Safety Foundation Say Preoperative Testing for COVID-19 is Essential, Regardless of Vaccination
American Society of Anesthesiologists (ASA)

All patients undergoing non-emergency surgeries or procedures should continue to have preoperative polymerase chain reaction (PCR) testing for SARS-CoV-2, irrespective of vaccination status, according to an updated guidance from the American Society of Anesthesiologists and Anesthesia Patient Safety Foundation.

Newswise: FAU Expert Answers Questions about Delta Variant, Vaccines and Public Safety
Released: 4-Aug-2021 12:35 PM EDT
FAU Expert Answers Questions about Delta Variant, Vaccines and Public Safety
Florida Atlantic University

Florida Atlantic University’s Joanna Drowos, D.O., M.P.H., M.B.A., Schmidt College of Medicine, provides answers to some of the most frequently asked questions regarding the COVID-19 Delta variant, vaccines and public safety measures.

Released: 4-Aug-2021 11:15 AM EDT
Rehabilitation Nurses Play Critical Role in Treating Patients with Long-Term Covid-19 Symptoms
Association of Rehabilitation Nurses

A new and free webinar from the Association of Rehabilitation Nurses (ARN) and the American Nurses Association (ANA) features advice from rehabilitation nurses to the greater nursing community about care priorities and interventions for long haul COVID-19 patients.

Newswise:Video Embedded spreading-doses-of-hope-as-covid-19-cases-rise
VIDEO
Released: 4-Aug-2021 10:35 AM EDT
Spreading ‘Doses of Hope’ as COVID-19 Cases Rise
Cedars-Sinai

In an emotional new series of videos, Black medical professionals plead for viewers to get a COVID-19 vaccine.

Newswise:Video Embedded american-college-of-surgeons-urges-surgeons-to-talk-it-up-with-patients-about-covid-19-vaccination
VIDEO
Released: 4-Aug-2021 10:00 AM EDT
American College of Surgeons Urges Surgeons to “Talk It Up” with Patients About COVID-19 Vaccination
American College of Surgeons (ACS)

ACS is launching a “Talk It Up” campaign to help surgeons address patient concerns and help them understand the importance of getting vaccinated against COVID-19.

28-Jul-2021 11:15 AM EDT
LEDs Light the Way to Coronavirus Disinfection
American Institute of Physics (AIP)

LEDs are commonly used for sterilization, and in the continued effort to combat the coronavirus pandemic, LEDs can also help inactivate SARS-CoV-2. A team in Pakistan designed far-ultraviolet LEDs at a targeted wavelength of 222 nanometers, chosen both for its ability to inactivate the virus and for being safe on human skin. They based their design on the material aluminum gallium nitride, part of a set of materials called III-nitrides which are efficient, inexpensive, and environmentally friendly.


Showing results

110 of 6123

close
1.41657